Financial Information

KemPharm® is a clinical stage, specialty pharmaceutical company engaged in the development and discovery of proprietary prodrugs that are designed to be improved versions of widely prescribed and FDA approved products.

Financial Information

Filing date Form Description Filing Group View
424B5

Form of prospectus disclosing information, facts, events covered in both forms 424B2, 424B3

Registration Statements
View HTML
S-8

Securities offered to employees pursuant to employee benefit plans

Registration Statements
View HTML
8-K

Report of unscheduled material events or corporate event

Current Reports
View HTML
4

Statement of changes in beneficial ownership of securities

3,4,5
View HTML
SC 13G/A

An amendment to the SC 13G filing

3,4,5
View HTML
SC 13G/A

An amendment to the SC 13G filing

3,4,5
View HTML
4

Statement of changes in beneficial ownership of securities

3,4,5
View HTML
4

Statement of changes in beneficial ownership of securities

3,4,5
View HTML
4

Statement of changes in beneficial ownership of securities

3,4,5
View HTML
4

Statement of changes in beneficial ownership of securities

3,4,5
View HTML